LAKE HILLS PHARMACY FORMULATION

BPC-157 – Injection

BPC-157

Level CLake Hills PharmacyCompounded Formula
BPC-157 – Injection

References are being re-verified against PubMed and will return with review dates.

C
Emerging Evidence
Preclinical and animal studies with limited human data

Preclinical and animal studies with limited human data

BPC-157, short for *Body Protective Compound-157*, is generating intense buzz in the worlds of sports medicine and recovery. First identified in the early 1990s as a naturally occurring gastric peptide, BPC-157 is believed to help protect and repair tissues. Athletes and clinicians alike are increasingly curious about its potential to speed recovery from musculoskeletal injuries — but the science is still catching up.

A new *systematic review* published in the *HSS Journal* (2025) analyzed 36 studies on BPC-157 and found compelling preclinical evidence that it improves healing in muscle, tendon, ligament, and bone injuries, while also reducing inflammation. Despite this, BPC-157 remains unapproved by the FDA and is banned in professional sports.

Reference: [HSS Journal Systematic Review 2025](https://pmc.ncbi.nlm.nih.gov/articles/PMC12313605/)

Clinically reviewed content

\n\nPreclinical Safety: - ✅ No acute toxicity demonstrated - ✅ No mutagenicity or teratogenicity - ✅ Good tolerance in animal models

Human Safety: - ⚠️ Limited data - primarily retrospective reports - ⚠️ Long-term effects unknown - ⚠️ Drug interactions not well studied

Contraindications: - Active malignancy (theoretical concern - promotes angiogenesis) - Pregnancy/lactation (insufficient data) - Uncontrolled bleeding disorders - Known hypersensitivity to peptides

Warnings: - Use only under medical supervision - Source quality is critical - Monitor for adverse effects - Limit duration until more data available

Immunogenicity Risk: As with any peptide therapy, there is potential for immune response. Studies suggest monitoring for hypersensitivity reactions (PMC12313605).\n\n

Contraindications: * Hypersensitivity to BPC-157 or formulation excipients * Pregnancy, lactation, or children (safety unestablished) * Active malignancy or immunosuppression (use only under specialist advice) * Use only under supervision by a knowledgeable provider

Important safety information above

Considerations

Common Protocols (from clinical practice and research): - Subcutaneous injection: 250-500 mcg daily - Course duration: 4-8 weeks for acute injuries - Maximum duration: 90 days (until more human data available) - Cycle approach: On-treatment courses with breaks

Monitoring: - Baseline inflammatory markers - Injury-specific imaging (MRI, ultrasound) - Symptom tracking - Adverse event surveillance

Clinically reviewed content

Lake Hills Pharmacy Formulation

Concentration

1.5mg/mL (Injectable), 0.5mg or 1mg per capsule

Available Vial Sizes

4mL vial, Capsule package

Route of Administration

Subcutaneous (SC) or Oral

Storage

Refrigerate 2-8°C

For Patients

Interested in BPC-157 – Injection? Connect with our medical team to discuss if this therapy is right for you.

or call us directly:

512-608-9355

For Healthcare Providers

New to Lake Hills Pharmacy? Join our network of providers offering evidence-based peptide therapy to your patients.

Partner with Lake Hills

Quick approval • Access to all formulations

Clinical View: Complete drug monograph with evidence-based protocols. Switch to General View for patient-friendly information.

Important Information About Compounded Medications

These peptides are not FDA-approved but are commonly used by providers and patients under medical supervision. These statements have not been evaluated by the FDA. These products are not intended to diagnose, treat, cure, or prevent any disease. We provide evidence-based information from current research to help navigate this evolving field. Our goal is to ensure access to safe, pure, potent products under professional oversight—not unregulated substances purchased online.

Lake Hills Pharmacy | Licensed 503A Compounding Pharmacy | USP 797/800 Compliant | Professional Medical Oversight Required